Lyterian Therapeutics

Lyterian Therapeutics focuses on biotechnology and small molecule therapeutics within the healthcare sector

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Lyterian Therapeutics focuses on biotechnology and small molecule therapeutics within the healthcare sector. The company develops medicines by using protein homeostatic mechanisms to regulate genetically validated targets for treating diseases.

02Backed By1 investor

TCThe Column Group→

03Similar Companies

PB

Is this your company? Claim your profile

Pluvia Biotech

Biotech & Life Sciences

→

SB

Sporos Bioventures

Biotech & Life Sciences

→

AT

ArCHitect Therapeutics

Biotech & Life Sciences

→

I

InduPro

Biotech & Life Sciences

→

S

Synthorx

Biotech & Life Sciences

→

04Startup DNA

7

signals

Sectors
Business Model
Technology